Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the …

…, M Böhm, D Duboc, J Gimeno, P de Groote… - European heart …, 2016 - academic.oup.com
In this paper the Working Group on Myocardial and Pericardial Disease proposes a revised
definition of dilated cardiomyopathy (DCM) in an attempt to bridge the gap between our …

Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure

P de Groote, A Millaire, C Foucher-Hossein… - Journal of the American …, 1998 - jacc.org
Objectives. We sought to study the relationship between survival and right ventricular ejection
fraction (RVEF) in a subgroup of patients with moderate congestive heart failure (CHF). …

Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study

…, Y Allanore, KP Tiev, P Clerson, P Groote… - Arthritis & …, 2005 - Wiley Online Library
Objective Screening allows for early management of pulmonary arterial hypertension (PAH),
a severe complication of systemic sclerosis (SSc). Since no consensus has been reached …

Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension

…, G Prevot, F Picard, P de Groote… - European …, 2017 - Eur Respiratory Soc
Current European guidelines recommend periodic risk assessment for patients with
pulmonary arterial hypertension (PAH). The aim of our study was to determine the association …

Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure

…, A Holzmann, G Lemesle, P de Groote… - Circulation …, 2014 - Am Heart Assoc
Rationale: Long noncoding RNAs represent a novel class of molecules regulating gene
expression. Long noncoding RNAs are present in body fluids, but their potential as biomarkers …

Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long‐term survival

M Humbert, A Yaici, P de Groote… - Arthritis & …, 2011 - Wiley Online Library
Pascal de Grootede Groote, Montani, and Sitbon's institution received an unrestricted
grant from Actelion for providing logistical support, monitoring, project … Pascal de Groote

Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open …

…, A Chaouat, V Cottin, P De Groote… - The Lancet …, 2022 - thelancet.com
Background Riociguat and balloon pulmonary angioplasty (BPA) are treatment options for
inoperable chronic thromboembolic pulmonary hypertension (CTEPH). However, randomised …

[HTML][HTML] Influence of diabetes mellitus on heart failure risk and outcome

…, E Van Belle, A Millaire, P De Groote - Cardiovascular …, 2003 - Springer
Our aim is to summarize and discuss the recent literature linking diabetes mellitus with heart
failure, and to address the issue of the optimal treatment for diabetic patients with heart …

Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients

…, D Launay, V Gaxotte, P de Groote… - Annals of the …, 2009 - ard.bmj.com
Objectives: To assess the prevalence and patterns of cardiac abnormalities as detected by
cardiac magnetic resonance imaging (MRI) in systemic sclerosis (SSc). Methods: Fifty-two …

Association between initial treatment strategy and long-term survival in pulmonary arterial hypertension

…, C Dauphin, B Degano, P De Groote… - American journal of …, 2021 - atsjournals.org
Pascal De GrootePascal De Groote … to privacy, information technology, and civil rights in
France (Commission Nationale de l’Informatique et des Libertés). The committee approved the …